Commonly reported side effects (incidence 5%) include: nausea, diarrhea, constipation, vomiting, injection site reactions, headache, low blood sugar, heartburn, fatigue (sleepiness), dizziness, stomach-area pain, increased lipase (a pancreatic enzyme), upper stomach-area pain, fever, and stomach infection (gastroenteritis)
Application of deoxygenated buffers adjusted to the isoelectric point of glutathione for stability
BMC Complement Med Ther 24:303
Buy Semasize (semaglutide) injection in India from Aark Pharmaceuticals Contact For any inquiries Description Description Semaglutide has been approved by the Drug Controller General of India for the treatment of Type 2 Diabetes Mellitus and chronic weight management, to be used alongside diet and exercise
W przypadku pojawienia si jakichkolwiek oznak podranienia, zaprzesta uywania produktu